2-Méthyl-1-butanol, min 97,5 %, pour la synthèse, 100 ml, emballage en verre

4-(Aminomethyl)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride, 98%, 50mg

N-Boc-7-Bromo-4-oxo-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine], 97.0%, 1g

Methyl 3-Hydroxybenzoate, 98.0%, 10g

10-Hydroxydecanoic Acid>97.0%(GC)(T)25g

Benzoic acid, 4-[[bis[(1,1-dimethylethoxy)carbonyl]amino][[(1,1- dimethylethoxy)carbonyl]imino]methyl]-, methyl ester, 98%, 250mg

3,5-Dibromo-2-(methylthio)pyridine, 95+%, 1g

3-Bromo-4,5-dimethylnitrobenzene, 95.0%, 10g

3,5-Difluoro-4-pyridinecarbonitrile, 95.0%, 25g

Dodecylamine acetate, 98.0%, 25g

(S)-6-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 100mg

Ethyl 4-cyclohexyl-3-oxobutanoate, 95.0%, 1g

2-Bromo-4-fluoro-5-nitrobenzoic acid, 95.0%, 5g